Conv. Plasma
Nigella Sativa

All vitamin D studies
Meta analysis
study COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Vitamin D status and blood group among severe COVID19 patients

Arayafar et al., Annals of Medicine & Surgery, doi:10.1097/MS9.0000000000000955
Jul 2023  
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments.
Retrospective 305 COVID-19 ICU patients in Iran, showing vitamin D deficiency associated with mortality.
Arayafar et al., 11 Jul 2023, retrospective, Iran, peer-reviewed, 3 authors.
This PaperVitamin DAll
Vitamin D Status and Blood Group among Severe COVID19 Patients
Mohamad Aryafar, Farshid Gholami, Rama Bozorgmehr
Objective: Prognosis of COVID-19 infection has been indicated to be associated with vitamin D status and ABO blood group. However, owing to discrepancies and an increased number of cases globally, the findings remain unclear. This study aimed to evaluate the association between vitamin D and ABO blood group systems in patients with severe COVID-19. Methods: In this cross-sectional study, COVID-19 patients referred to two hospitals in the capital of Iran, Tehran, admitted to the ICU ward due to the severity of COVID-19 were evaluated. Serum vitamin D and ABO levels were evaluated in these patients. The data obtained were statistically analyzed using SPSSv24. Results: Of 305 patients, 33.1% patients had O+ blood type, 27.8% had A+ blood type and 22.4% had B+ blood type. Vitamin D deficiency was significantly associated with a mortality rate among these patients, p < 0.05. The blood group of the patients was not correlated with mortality. 37% of the patients in the study died because of COVID-19. Conclusion: In our study population, mortality due to COVID-19 was significantly associated with vitamin D deficiency but not the ABO blood group. We recommend further studies in this regard that include more variable and detailed biochemical analysis.
Ahmadinejad, Ahmadinejad, Soltanian, Mardasi, Taherzade, Using new technicque in sigmoid volvulus surgery in patients affected by COVID19, Ann Med Surg
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity
Almadhi, Abdulrahman, Alawadhi, Rabaan, Atkin et al., The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes, Sci Rep
Arend, Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates, Immunobiology
Argano, Bocchio, Natoli, Scibetta, Monaco et al., Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis, Pharmaceuticals
Farzan, Vahabi, Madani, Farzan, Evaluating characteristics associated with the mortality among invasive ventilation COIVD -19 patients, Ann Med Surg
Franceschi, Santos, Glaeser, Paiz, Caldana et al., Population-based prevalence surveys during the Covid-19 pandemic: A systematic review, Rev Med Virol
Gutiérrez-Valencia, Leache, Librero, Jericó, Germán et al., ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis, Transfusion
Latz, Decarlo, Boitano, Png, Patell et al., Blood type and outcomes in patients with COVID-19, Ann Hematol
Leaf, Al-Samkari, Brenner, Gupta, Leaf, ABO phenotype and death in critically ill patients with COVID-19, Br J Haematol
Li, Yang, Zhao, Zhi, Wang et al., Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China, Clin Res Cardiol
Liao, Xue, Gao, Wu, Kou, ABO blood group-associated susceptibility to norovirus infection: A systematic review and meta-analysis, Infect Genet Evol
Mathew, Agha, Group, STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery, Int J Surg Lond Engl
Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, JAMA Netw Open
Pdf, Association of Abo Blood Group and Rh Factor with Malaria and Some Gastrointestinal Infectious Disease in a Population of Adet and Merawi, Ethiopia | Semantic Scholar
Singh, Srivastava, Upadhyay, Singh, Upadhyay et al., The association of ABO blood group with the asymptomatic COVID-19 cases in India, Transfus Apher Sci
Vahabi, Veiskarami, Roozbahani, Lashani, Farzan, Cross-sectional study on hearing loss and auditory reaction time before and after spinal anesthesia with marcaine 0.5% in patients undergoing elective surgery, Ann Med Surg
Vitamin, Health -Pmc, None
Wu, Feng, Li, Yu, Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19, Clin Chim Acta Int J Clin Chem
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharideinduced acute lung injury via regulation of the renin-angiotensin system, Mol Med Rep
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop